No Data
No Data
Chimerix Shares Top 52-week Highs, Company Plans FDA Submission of Cancer Drug Dordaviprone
Chimerix CMRX NDA Plans; UniQure QURE Accelerated Approval Path
Dow Falls 150 Points; Oracle Posts Downbeat Results
Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?
Wall Street Set to Open Flat Tuesday as Investors Await Inflation Data
TD Cowen Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $8